FDA advises how to manufacture abuse-resistant pain drugs

NEWS IN BRIEF — Posted Jan. 21, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration on Jan. 9 issued a proposal to help the pharmaceutical industry develop new formulations of opioids with abuse-deterrent properties.

The FDA document explains the agency’s views on the types of studies that should be conducted to demonstrate that a formulation can curb abuse, and it tells how the agency will evaluate those studies. The draft guidance also highlights the kinds of labeling claims that can be approved based on the study results (link). The agency was required to issue the proposed guidance under the FDA Safety and Innovation Act of 2012.

Opioids contribute to an estimated 15,000 U.S. deaths and more than 340,000 emergency department visits annually, according to the Centers for Disease Control and Prevention.

Abuse-deterrent formulations target the known or expected routes of drug abuse for a particular opioid substance in a pain medication, the FDA said. Routes of drug abuse include crushing a pill to snort it and dissolving a pill so it can be injected. Because the science of abuse deterrence is relatively new, the FDA said it will take a flexible, adaptive approach to the evaluation and labeling of potentially abuse-deterrent products.

The agency is seeking public comment on the draft for 60 days (link). It will consider information received from the public when it finalizes the document.

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn